Stressed Insulin Cells Spark Their Own Inflammation in Animals
Graded Preliminary — experiments in cells, mice, pigs and monkeys point to a mechanism, but there are no data on treating people.
Animal study. Findings may not carry over to people, which is why the grade is capped at Preliminary.
- Design
- Animal study
- Participants
- N/A
- Duration
- —
- Funding
- —
In animals, cell stress makes insulin cells trigger inflammation, which NMN or combined blockers were able to dampen.
In diabetes, the cells in the pancreas that make insulin slowly fail. Long-lasting inflammation drives that decline. Experiments in cells, mice and pigs now point to these cells starting the inflammation themselves when they are under stress.
It begins with mild stress from aggressive oxygen compounds. This disturbs the cells' power plants, the mitochondria, and a molecule called NAD+ runs low. The cell then tags an alarm protein, HMGB1, with extra chemical marks. The protein leaves the cell's nucleus and sets off inflammation. This tagging was much stronger in insulin cells than in immune or liver cells. A second signalling pathway made it worse. The team gave NMN, a building block of NAD+, or blocked both stress pathways, and inflammation eased. Combined approaches worked better than single ones, cutting inflammation markers by about 73 percent. Tests in monkeys were meant to show the approach is feasible in a more human-like body.
No person was treated. Whether NMN or other drugs help people with diabetes was not tested.
Disclaimer: Research summaries are provided for informational purposes only and do not constitute medical advice. Always consult a qualified healthcare professional before making changes to your health routine.
